Aardvark Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Aardvark Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial (NCT06828861) | Aardvark Therapeutics, Inc. | 2024-12-20 |
| A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder (NCT06126653) | Aardvark Therapeutics, Inc. | 2024-08-01 |
| The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial (NCT07197034) | Aardvark Therapeutics, Inc. | 2024-07-23 |
| A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome (NCT05153434) | Aardvark Therapeutics, Inc. | 2022-05-27 |
| Study to Evaluate ARD-101 in Adults With Obesity (NCT05121441) | Aardvark Therapeutics, Inc. | 2021-11-15 |
Track Aardvark Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.